|
1
|
Fitzmaurice C, Akinyemiju TF, Al Lami FH,
Alam T, Alizadeh-Navaei R, Allen C, Alsharif U, Alvis-Guzman N,
Amini E, Anderson BO, et al: Global, regional, and national cancer
incidence, mortality, years of life lost, years lived with
disability, and disability-adjusted life-years for 29 cancer
groups, 1990 to 2016: A systematic analysis for the global burden
of disease study. JAMA Oncol. 4:1553–1568. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–81. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Q, Yang W, Wang X, Li X, Qi S, Zhang
Y and Gao MQ: TGF-beta1 induces EMT in bovine mammary epithelial
cells through the TGFbeta1/Smad signaling pathway. Cell Physiol
Biochem. 43:82–93. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeh YC, Wei WC, Wang MG, Lin SC, Sung JM
and Tang MJ: Transforming growth factor-β1 induces smad3-dependent
β 1, integrin gene expression in epithelial-to-mesenchymal
transition during chronic tubulointerstitial fibrosis. Am J Pathol.
177:743–1754. 2010. View Article : Google Scholar
|
|
6
|
Attisano L and Wrana JL: Signal
transduction by the TGF-beta superfamily. Science. 296:1646–1647.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hwangbo C, Tae N, Lee S, Kim O, Park OK,
Kim J, Kwon SH and Lee JH: Syntenin regulates TGF-β1-induced Smad
activation and the epithelial-to-mesenchymal transition by
inhibiting caveolin-mediated TGF-β type I receptor internalization.
Oncogene. 35:389–401. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–42. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miettinen PJ, Ebner R, Lopez AR and
Derynck R: TGF-beta induced transdifferentiation of mammary
epithelial cells to mesenchymal cells: Involvement of type I
receptors. J Cell Biol. 127:2021–2036. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Derynck R and Zhang YE: Smad-dependent and
smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin XL, Liu M, Liu Y, Hu H, Pan Y, Zou W,
Fan X and Hu X: Transforming growth factor beta1 promotes migration
and invasion in HepG2 cells: Epithelialtomesenchymal transition via
JAK/STAT3 signaling. Int J Mol Med. 41:129–136. 2017.PubMed/NCBI
|
|
12
|
Kim JY, An HJ, Kim WH, Gwon MG, Gu H, Park
YY and Park KK: Anti-fibrotic effects of synthetic
oligodeoxynucleotide for TGF-beta1 and smad in an animal model of
liver cirrhosis. Mol Ther Nucleic Acids. 8:250–263. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boldbaatar A, Lee S, Han S, Jeong AL, Ka
HI, Buyanravjikh S, Lee JH, Lim JS, Lee MS and Yang Y: Eupatolide
inhibits the TGF-beta1-induced migration of breast cancer cells via
downregulation of SMAD3 phosphorylation and transcriptional
repression of ALK5. Oncol Lett. 14:6031–6039. 2017.PubMed/NCBI
|
|
14
|
Wang Y, Liu X, Zheng H, Wang Q, An L and
Wei G: Suppression of CUL4A attenuates TGF-beta1-induced
epithelial-to-mesenchymal transition in breast cancer cells. Int J
Mol Med. 40:1114–1124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Le Roy C and Wrana JL: Clathrin- and
non-clathrin-mediated endocytic regulation of cell signalling. Nat
Rev Mol Cell Biol. 6:112–26. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Midgley AC, Rogers M, Hallett MB, Clayton
A, Bowen T, Phillips AO and Steadman R: Transforming growth
factor-beta1 (TGF-beta1)-stimulated fibroblast to myofibroblast
differentiation is mediated by hyaluronan (HA)-facilitated
epidermal growth factor receptor (EGFR) and CD44 co-localization in
lipid rafts. J Biol Chem. 288:14824–14838. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YG: Endocytic regulation of TGF-beta
signaling. Cell Res. 19:58–70. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Xia K, Xiong M, Wang X and Yan N:
Effects of sepsis on the metabolism of sphingomyelin and
cholesterol in mice with liver dysfunction. Exp Ther Med.
14:5635–5640. 2017.PubMed/NCBI
|
|
19
|
Taniguchi M and Okazaki T: The role of
sphingomyelin and sphingomyelin synthases in cell death,
proliferation and migration-from cell and animal models to human
disorders. Biochim Biophys Acta. 1841:692–703. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeang C, Ding T, Chirico WJ and Jiang XC:
Subcellular targeting domains of sphingomyelin synthase 1 and 2.
Nutr Metab (Lond). 8:892011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Torki S, Soltani A, Shirzad H, Esmaeil N
and Ghatrehsamani M: Synergistic antitumor effect of NVP-BEZ235 and
CAPE on MDA-MB-231 breast cancer cells. Biomed Pharmacother.
92:39–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo S, Pan Z, Liu S, Yuan S and Yan N:
Sphingomyelin synthase 2 overexpression promotes cisplatin-induced
apoptosis of HepG2 cells. Oncol Lett. 15:483–488. 2018.PubMed/NCBI
|
|
23
|
Yan N, Ding T, Dong J, Li Y and Wu M:
Sphingomyelin synthase overexpression increases cholesterol
accumulation and decreases cholesterol secretion in liver cells.
Lipids Health Dis. 10:462011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu S, Ding Y, Gong J and Yan N:
Sphingomyelin synthase 2 affects CD14 associated induction of
NFkappaB by lipopolysaccharides in acute lung injury in mice. Mol
Med Rep. 14:3301–3306. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kwiatkowska E, Wojtala M, Gajewska A,
Soszynski M, Bartosz G and Sadowska-Bartosz I: Effect of
3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7
and invasive MDA-MB-231 breast cancer cells. J Bioenerg Biomembr.
48:23–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Xia J, Liu S, Stein S, Ramon C, Xi
H, Wang L, Xiong X, Zhang L, He D, et al: Endocytosis and membrane
receptor internalization: Implication of F-BAR protein carom. Front
Biosci (Landmark Ed). 22:1439–1457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Conner SD and Schmid SL: Regulated portals
of entry into the cell. Nature. 422:37–44. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mitchell H, Choudhury A, Pagano RE and
Leof EB: Ligand-dependent and -independent transforming growth
factor-beta receptor recycling regulated by clathrin-mediated
endocytosis and Rab11. Mol Biol Cell. 15:4166–4178. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Razani B, Zhang XL, Bitzer M, von
Gersdorff G, Bottinger EP and Lisanti MP: Caveolin-1 regulates
transforming growth factor (TGF)-beta/SMAD signaling through an
interaction with the TGF-beta type I receptor. J Biol Chem.
276:6727–6738. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang B, Paffett ML, Naik JS, Jernigan NL,
Walker BR and Resta TC: Cholesterol regulation of pulmonary
endothelial calcium homeostasis. Curr Top Membr. 82:53–91. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang SS, Liu IH, Chen CL, Chang JM,
Johnson FE and Huang JS: 7-Dehydrocholesterol (7-DHC), but not
cholesterol, causes suppression of canonical TGF-beta signaling and
is likely involved in the development of Atherosclerotic
Cardiovascular Disease (ASCVD). J Cell Biochem. 118:1387–1400.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen CL, Wu DC, Liu MY, Lin MW, Huang HT,
Huang YB, Chen LC, Chen YY, Chen JJ, Yang PH, et al:
Cholest-4-en-3-one attenuates TGF-beta responsiveness by inducing
TGF-beta receptors degradation in Mv1Lu cells and colorectal
adenocarcinoma cells. J Recept Signal Transduct Res. 37:189–199.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang SS, Chen CL, Huang FW, Hou WH and
Huang JS: DMSO enhances TGF-beta activity by recruiting the type II
TGF-beta receptor from intracellular vesicles to the plasma
membrane. J Cell Biochem. 117:1568–1579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang SS, Chen CL, Huang FW, Johnson FE
and Huang JS: Ethanol enhances TGF-beta activity by recruiting
TGF-beta receptors from intracellular vesicles/lipid rafts/caveolae
to non-lipid raft microdomains. J Cell Biochem. 117:860–871. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen CL, Huang SS and Huang JS: Cellular
heparan sulfate negatively modulates transforming growth
factor-beta1 (TGF-beta1) responsiveness in epithelial cells. J Biol
Chem. 281:11506–11514. 2006. View Article : Google Scholar : PubMed/NCBI
|
